Comprehensive characterization of the cellular and molecular consequences of LCN2 loss in MDA-MB-231 triple-negative breast cancer cells
Abstract
Triple-negative breast cancer (TNBC) is an aggressive breast cancer subtype characterized by high metastatic potential and limited targeted therapeutic options. Lipocalin-2 (LCN2) has been implicated in tumor progression and metastatic dissemination, but its functional role in TNBC remains incompletely understood. This study investigated the role of LCN2 in the human TNBC cell line MDA-MB-231. Stable LCN2-deficient (LCN2KO) cells were generated using CRISPR/Cas9 genome editing, followed by isolation of single-cell-derived clones. RNA sequencing was performed to characterize transcriptomic changes, with selected findings validated by reverse transcription quantitative PCR (RT-qPCR). Western blotting was used to assess protein-level changes. Transwell migration and invasion assays and adhesion assays were performed to evaluate functional effects. LCN2KO cells largely retained the mesenchymal phenotype of parental cells. RNA sequencing revealed changes associated with inflammatory signaling, iron homeostasis, oxidative stress, ferroptosis-related processes, and cellular metabolism. Functional assays demonstrated reduced migration, invasion, and adhesion, accompanied by altered adhesion to extracellular matrix components. LCN2 deficiency is associated with transcriptional and functional changes in MDA-MB-231 cells, particularly affecting migratory and invasive behavior and cell–matrix interactions, while largely preserving the mesenchymal phenotype. These findings provide further insight into the role of LCN2 in cellular processes relevant to TNBC progression and metastatic behavior.